Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$5.28 - $18.9 $1.09 Million - $3.9 Million
-206,248 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$12.92 - $27.18 $95,091 - $200,044
-7,360 Reduced 3.45%
206,248 $3.62 Million
Q4 2021

Feb 14, 2022

BUY
$21.96 - $42.69 $1.81 Million - $3.52 Million
82,388 Added 62.79%
213,608 $5.63 Million
Q3 2021

Nov 15, 2021

BUY
$41.3 - $54.56 $1.81 Million - $2.38 Million
43,710 Added 49.95%
131,220 $5.53 Million
Q2 2021

Aug 16, 2021

BUY
$38.61 - $55.0 $138,339 - $197,065
3,583 Added 4.27%
87,510 $4.75 Million
Q1 2021

May 13, 2021

BUY
$38.1 - $59.09 $3.2 Million - $4.96 Million
83,927 New
83,927 $3.81 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $250M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.